Learn More
Medchemexpress LLC 4-isothiazolecarboxamide, 3-[(4-bromo-2,6-difluorophenyl)methoxy]-5-(pyrrolidinylbutyl)amino trifluoroacetate | 2805804-54-8 | 98.0% | C22H25BrF5N5O5S | 10MG

Supplier: Medchemexpress LLC HY13302C10MG
CP-547632 TFA is an orally active, ATP-competitive inhibitor of VEGFR-2 and FGF kinases with potent enzymatic activity (IC50 ≈ 11 nM for VEGFR-2 and ≈ 9 nM for FGF). Supplied as the trifluoroacetate (TFA) salt for research use, it has demonstrated antitumor efficacy in xenograft models and is characterized by comprehensive analytical documentation.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.